546 related articles for article (PubMed ID: 26140405)
1. Clinical analysis of spinal stereotactic radiosurgery in the treatment of neurogenic tumors.
Shin DW; Sohn MJ; Kim HS; Lee DJ; Jeon SR; Hwang YJ; Jho EH
J Neurosurg Spine; 2015 Oct; 23(4):429-37. PubMed ID: 26140405
[TBL] [Abstract][Full Text] [Related]
2. Foraminal nerve sheath tumors: intermediate follow-up after cyberknife radiosurgery.
Murovic JA; Gibbs IC; Chang SD; Mobley BC; Park J; Adler JR
Neurosurgery; 2009 Feb; 64(2 Suppl):A33-43. PubMed ID: 19165072
[TBL] [Abstract][Full Text] [Related]
3. Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.
Safaee M; Parsa AT; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Tihan T; Ames CP
Neurosurg Focus; 2015 Aug; 39(2):E5. PubMed ID: 26235022
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery yields long-term control for benign intradural, extramedullary spinal tumors.
Sachdev S; Dodd RL; Chang SD; Soltys SG; Adler JR; Luxton G; Choi CY; Tupper L; Gibbs IC
Neurosurgery; 2011 Sep; 69(3):533-9; discussion 539. PubMed ID: 21832967
[TBL] [Abstract][Full Text] [Related]
5. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
6. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
7. Neurological outcomes and surgical complications in 221 spinal nerve sheath tumors.
Safaee MM; Lyon R; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Chin CT; Tihan T; Ames CP
J Neurosurg Spine; 2017 Jan; 26(1):103-111. PubMed ID: 27472744
[TBL] [Abstract][Full Text] [Related]
8. Radiosurgery for benign tumors of the spine: clinical experience and current trends.
Gerszten PC; Quader M; Novotny J; Flickinger JC
Technol Cancer Res Treat; 2012 Apr; 11(2):133-9. PubMed ID: 22335407
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
10. Radiosurgery for benign tumors of the spine using the Synergy S with cone-beam computed tomography image guidance.
Gerszten PC; Chen S; Quader M; Xu Y; Novotny J; Flickinger JC
J Neurosurg; 2012 Dec; 117 Suppl():197-202. PubMed ID: 23205810
[TBL] [Abstract][Full Text] [Related]
11. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for primary malignant spinal tumors.
Chang UK; Lee DH; Kim MS
Neurol Res; 2014 Jun; 36(6):597-606. PubMed ID: 24773479
[TBL] [Abstract][Full Text] [Related]
13. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
14. [Pathologic characteristics of the most frequent peripheral nerve tumors].
Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
[TBL] [Abstract][Full Text] [Related]
15. Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
Carlson ML; Jacob JT; Habermann EB; Glasgow AE; Raghunathan A; Link MJ
J Neurosurg; 2016 Nov; 125(5):1120-1129. PubMed ID: 26745487
[TBL] [Abstract][Full Text] [Related]
16. The surgical management of symptomatic peripheral nerve sheath tumors.
Levi AD; Ross AL; Cuartas E; Qadir R; Temple HT
Neurosurgery; 2010 Apr; 66(4):833-40. PubMed ID: 20190660
[TBL] [Abstract][Full Text] [Related]
17. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
18. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
19. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
[TBL] [Abstract][Full Text] [Related]
20. A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(5):5113-20. PubMed ID: 26191206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
